FDA Adverse Event Malfunction Summary report: N

IMMULITE 2000 TOXOPLASMA QUANTITATIVE IGG

MDR report key: 4190564 · Received October 21, 2014

Report

Report Number
2432235-2014-00610
Event Type
Malfunction
Date Received
October 21, 2014
Date of Event
September 20, 2014
Report Date
September 25, 2014
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
LGD
PMA / PMN Number
K962936
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GR
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE INITIAL MDR # 2432235-2014-00610 WAS FILED ON OCTOBER 21, 2014.ADDITIONAL INFORMATION (12/12/2014): THE REGIONAL SUPPORT CENTER SPECIALIST SPOKE TO THE CUSTOMER. THE CUSTOMER DOES NOT HAVE SAMPLES FROM THE PATIENT AVAILABLE FOR TESTING. THE CAUSE OF THE DISCORDANT TOXOPLASMA QUANTITATIVE IGG RESULTS ON SAMPLES FROM ONE PATIENT IS UNKNOWN.

Additional Manufacturer Narrative · 1

THE CAUSE FOR THE FALSE POSITIVE TOXOPLASMA QUANTITATIVE IGG RESULTS ARE UNKNOWN. SIEMENS HEALTHCARE DIAGNOSTICS IS INVESTIGATING THE ISSUE.

Description of Event or Problem · 1

THE CUSTOMER OBTAINED FALSE POSITIVE RESULTS ON ONE PATIENT SAMPLE FOR TOXOPLASMA QUANTITATIVE IGG (TXP) ON AN IMMULITE 2000 XPI INSTRUMENT WHEN USING REAGENT LOT 406. THE SAME SAMPLE WAS REPEATED WHICH ALSO RESULTED POSITIVE. A NEW SAMPLE WAS OBTAINED FROM THE PATIENT AND TESTED ON THE IMMULITE INSTRUMENT, WHICH AGAIN RESULTED AS POSITIVE. THE FALSE POSITIVE RESULTS WERE NOT REPORTED TO THE PHYSICIAN(S). THE NEW SAMPLE WAS THEN TESTED ON ADVIA CENTAUR XP WHICH RESULTED AS NEGATIVE. THE CORRECTED RESULT WAS REPORTED TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSE POSITIVE RESULTS OF TOXO IGG ON THE PATIENT SAMPLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
667850 IMMULITE 2000 TOXOPLASMA QUANTITATIVE IGG IMMULITE 2000 TOXOPLASMA QUANTITATIVE IGG LGD SIEMENS HEALTHCARE DIAGNOSTICS INC. IMMULITE 2000 406

Patients

Seq Age Sex Outcome Treatment
1